CGRP” medications, the drug didn’t meet some analysts’ expectations in mid-stage testing but still convinced Lundbeck to ...

Thousands of Australians living with frequent migraines will now be able to access a treatment many describe as life-changing ...

The SPACE trial showed fremanezumab significantly reduced monthly migraine days in pediatric patients compared with placebo. The Food and Drug Administration (FDA) has accepted for review the ...

Thirteen percent of Americans—about 38 million people—suffer from migraine, and every one of them has a different experience with the condition. Treatment has to be as individualized as they are.

CT-132 statistically significantly reduced monthly migraine days compared with sham digital treatment after 12 weeks. The Food and Drug Administration (FDA) has granted marketing authorization to ...

Viral migraine hacks may provide temporary relief, but experts say lasting migraine control depends on lifestyle changes and ...

Migraine sufferers are no strangers to major headaches. The onset of a migraine can be painful, disorienting and sometimes even debilitating. During National Migraine and Headache Awareness Month, Fox ...

From June 1, the migraine prevention drug Emgality has been expanded on the Pharmaceutical Benefits Scheme, making it ...

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks. On Thursday, the US Food and Drug ...

"I lost my highly successful career in PR because I couldn’t regularly show up for my clients." ...

A new study suggests that people who experience migraines, especially chronic migraines, could show signs of faster brain ...